Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Human recombinant migration inhibitory factor activates human macrophages to kill Leishmania donovani.

Weiser WY, Pozzi LM, David JR. Human recombinant migration inhibitory factor activates human macrophages to kill Leishmania donovani. J Immunol. 1991 Sep 15; 147(6):2006-11.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.